Company Profile

Year Established : 2021
Total Assets(USD) : More than 99,999,999
Total Number of Staff : 10-50
Main Competitive Advantages : Brand Name,International Approvals/Standards,Experienced R&D Staff,Small Orders Accepted,Quality Service
Other Competitive Advantages : R&D Team (1)Stable R&D team with over 10 years of experience, more than 20 successful R&D projects. (2)Synthesis Lab with GRLP standard. (3)Analysis Lab in accordance with GMP conditions. (4)In collaboration with well-known universities, focus on new salt, new crystal form and novel technologies, such as synthetic biology and continuous-flow synthetic.
  • Contact Person :
  • Fax:

Focus on natural origin and oncology APIs, setting up R&D and production platform for new salt and crystal form, deep cooperation with clients for IND, NDA, ANDA, 505b(2) or P-IV challenge.

Explore the potential of macromolecular APIs, setting up R&D and production platform for Glycans and polypeptide.

Specialized in XDC drugs field, committed to platform building for the innovative research and production on payload and Best-Link.

Global registration platform, professional team,  and international cGMP system.

API  CDMO service with global registration.

Strategy: FDF + APIs.

Tel: +86-28-17360040767

Website: www.xielipharm.com.cn、www.elixir-pharm.com

PharmaSources Customer Service